Delivery Order 75N91019D00012-75N91021F00001
Award Date 9/6/21
Potential Completion Date 7/31/24
Potential Value $533K
Federal Agency
Awardee
Ultimate Awardee
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60616, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award from the National Cancer Institute (NCI) to the IIT Research Institute (IITRI), a division of the Illinois Institute of Technology, is for a $596,209 Firm Fixed Price Delivery Order under the "PREVENT Cancer Program (PREVENT)" contract vehicle. The contract is for the "NOVEL ANDROGEN RECEPTOR ANTAGONIST-MEDIATED CHEMOPREVENTION OF PROSTATE CANCER" project, which aims to conduct preclinical research to support the development of therapies for...
- The National Cancer Institute awarded a definitive cost-plus-fixed-fee contract to IIT Research Institute (IITRI), a non-profit contract research organization and subsidiary of the Illinois Institute of Technology, for preclinical toxicology and pharmacology services supporting drug development for cancer, AIDS, and AIDS-related illnesses. The contract, awarded on April 1, 2004, carries a ceiling value of $159.3 million with an ultimate completion date of June 30, 2016, and will be performed...
- This is a Cost Plus Fixed Fee contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The $23,349,236 contract is for the provision of preclinical in vitro and in vivo screening assays to support the development of cancer preventive agents. IITRI, which has extensive experience supporting the preclinical development of various therapeutics for federal...
- This federal contract award is for $2,708.00 to the IIT Research Institute (IITRI), a non-profit division of the Illinois Institute of Technology (IIT), to provide contract orientation and kickoff meeting services for R&D under the "Preclinical Toxicology of Small Molecule Drugs Developed for Cancer and Other Indications" program. The contract is being issued by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services. IITRI...
- The National Cancer Institute awarded a $1.89 million cost-plus-fixed-fee delivery order to IIT Research Institute (IITRI) on September 16, 2024, for toxicology studies in rats and dogs involving the experimental compound AIT-102. The work will be performed in Chicago, Illinois, with a completion date of June 30, 2026. This delivery order was issued under one of IITRI's existing indefinite delivery/indefinite quantity (IDIQ) contract vehicles with NCI—specifically the $149.995 million PREVENT...
- The National Cancer Institute awarded a $68,323 firm fixed-price delivery order to IIT Research Institute (IITRI) for toxicology studies in mice administered MTX-531, with a final completion date of May 9, 2026. This delivery order, which carries no set-aside designation, represents work performed under one of IITRI's larger Indefinite Delivery/Indefinite Quantity (IDIQ) vehicles—the $149.995 million PREVENT Cancer Preclinical Drug Development Program with the National Cancer Institute. The work...
- This is a $1,790,042.00 Delivery Order Contract awarded by the National Cancer Institute (NCI) to the IIT Research Institute (IITRI), a non-profit subsidiary of the Illinois Institute of Technology (IIT). The contract is for toxicology studies in mice and dogs administered MTX-531, which does not have a set-aside designation. IITRI is a leading preclinical contract research organization that specializes in providing drug development services to federal agencies like the NCI, NIAID, NINDS, and...
- This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The $4,145 contract is for a pre-clinical toxicology study of a drug developed for cancer patients, as part of the Toxicology of Drugs Developed for Cancer Patients contract vehicle. IITRI specializes in preclinical drug development services and has...
- This federal contract award, valued at $33,483,214.15, was issued by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The contract is for preclinical pharmacology and toxicology studies to support the development of small molecule, biologic, and RNA therapeutic candidates across various disease areas. IITRI has extensive experience providing these services to...
- This is a $718,265.00 delivery order awarded by the National Cancer Institute (NCI) of the Department of Health and Human Services (HHS) to IIT Research Institute, the research and technology development arm of Illinois Institute of Technology (IIT). The contract supports preclinical toxicology and pharmacology research for drugs developed for cancer patients, including exploratory studies of CCR4 CAR T cells. This work is performed under the NCI's "Toxicology of Drugs Developed for...